The United States has undergone several changes in foreign and domestic policy since US President Donald Trump took office in January. Scientists who rely on federal grants for their work have been ...
MedPage Today on MSN6d
mRNA Vaccines, Once a Trump Boast, Now Face Attacks From Some in GOPThe Florida surgeon general in January 2024 called for a halt in the use of COVID mRNA vaccines. And in Texas, Attorney ...
ZME Science on MSN2d
Finally, mRNA vaccines against cancer are starting to become a realityRNA vaccines were first developed years ago to target cancers and now they're really starting to show promise.
A vaccine kept patients free of pancreatic cancer for years, yet new reports say the NIH is advising against mentioning mRNA tech in grants.
Findings show potential for new lipid-based delivery formulations as a platform technology for immunizationPhiladelphia, PA, ...
Radiation therapy is a powerful tool for fighting cancer, but it comes with painful side effects. About 60% of cancer ...
Discover Magazine on MSN2d
Triggering Cancer Cells To Self-Destruct Could Help Tumors to ShrinkNatural "off switch" could slow or even reverse the growth of aggressive tumors.
Targeted CRISPR lipid nanoparticles eliminated 50% of tumors in mice with head and neck cancer.
Welcome to Maravai LifeSciences fourth quarter 2024 results earnings call. At this time, all participants are in a ...
Our study highlights the decline of UPF1, a key component of nonsense-mediated mRNA ... of RNA Pol II, the authors show the regulation of transcription by TBPL1 and PAF1 within ribosomal DNA ...
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback